EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion

Vignan Yogendrakumar iD, Sarah Vandelanotte, Eva A Mistry iD, Michael D Hill iD, Shelagh B Coutts iD, Raul G Nogueira iD, Thanh N Nguyen iD, Robert L Medcalf iD, Joseph P Broderick iD, Simon F De Meyer iD, Bruce C V Campbell iD

Stroke · 2024-10 · 55 (10) · 2536-2546

DOI: 10.1161/strokeaha.124.045755 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stroke, 2024-10. Verfasst von Vignan Yogendrakumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, The Ottawa Hospital and Ottawa Hospital Research Institute, University of Ottawa, Canada (V.Y.). Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombolytic Therapy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombolytic therapies for acute ischemic stroke are widely available but only result in recanalization early enough, to be therapeutically useful, in 10% to 30% of cases. This large gap in treatment effectiveness could be filled by novel therapies that can increase the effectiveness of thrombus clearance without significantly increasing the risk of harm. This focused update will describe the current state of emerging adjuvant treatments for acute ischemic stroke reperfusion. We focus on new treatments that are designed to (1) target different components that make up a stroke thrombus, (2) enhance endogenous fibrinolytic systems, (3) reduce stagnant blood flow, and (4) improve recanalization of distal thrombi and postendovascular thrombectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeThrombolytic TherapyHumansFibrinolytic AgentsReperfusionThrombectomyBrain IschemiaAnimalsStroke

Stichwörter der Autor:innen

reperfusionstrokethrombectomythrombolytic therapytreatment outcome

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Division of Neurology, The Ottawa Hospital and Ottawa Hospital Research Institute, University of Ottawa, Canada (V.Y.).
  • Department of Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Australia (V.Y., B.C.V.C.).
  • Laboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium (S.V., S.F.D.M.).
  • Department of Neurology and Rehabilitation Medicine, University of Cincinnati, OH (E.A.M., J.P.B.).
  • Department of Clinical Neurosciences, Radiology, and Community Health Sciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Canada (M.D.H., S.B.C.).
  • Department of Neurology, University of Pittsburgh, PA (R.G.N.).

ORCID-Profile: Vignan Yogendrakumar, Eva A Mistry, Michael D Hill, Shelagh B Coutts, Raul G Nogueira, Thanh N Nguyen, Robert L Medcalf, Joseph P Broderick, Simon F De Meyer, Bruce C V Campbell

Zitieren

APA

Yogendrakumar, V., Vandelanotte, S., Mistry, E. A., Hill, M. D., Coutts, S. B., Nogueira, R. G., Nguyen, T. N., Medcalf, R. L., Broderick, J. P., De Meyer, S. F., & Campbell, B. C. V. (2024). Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion. Stroke, 55(10), 2536-2546. https://doi.org/10.1161/strokeaha.124.045755

Vancouver

Yogendrakumar V, Vandelanotte S, Mistry EA, Hill MD, Coutts SB, Nogueira RG, et al. Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion. Stroke. 2024;55(10):2536-2546. doi:10.1161/strokeaha.124.045755

BibTeX
@article{Yogendrakumar2024,
  author = {Yogendrakumar, Vignan and Vandelanotte, Sarah and Mistry, Eva A and Hill, Michael D and Coutts, Shelagh B and Nogueira, Raul G and Nguyen, Thanh N and Medcalf, Robert L and Broderick, Joseph P and De Meyer, Simon F and Campbell, Bruce C V},
  title = {Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion},
  journal = {Stroke},
  year = {2024},
  volume = {55},
  number = {10},
  pages = {2536--2546},
  doi = {10.1161/strokeaha.124.045755}
}
Kostenlos starten →